Everpar Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$562K Buy
6,199
+1,182
+24% +$108K 0.16% 133
2026
Q1
$515K Buy
5,017
+1,212
+32% +$137K 0.18% 131
2025
Q4
$477K Sell
3,805
-658
-15% -$83.8K 0.18% 132
2025
Q3
$598K Buy
4,463
+40
+0.9% +$5.25K 0.24% 98
2025
Q2
$602K Buy
4,423
+437
+11% +$57.6K 0.27% 88
2025
Q1
$529K Buy
3,986
+1,029
+35% +$131K 0.28% 87
2024
Q4
$334K Buy
2,957
+134
+5% +$15.5K 0.17% 167
2024
Q3
$322K Buy
2,823
+8
+0.3% +$877 0.17% 181
2024
Q2
$293K Sell
2,815
-7
-0.2% -$742 0.15% 194
2024
Q1
$321K Sell
2,822
-1,482
-34% -$170K 0.2% 170
2023
Q4
$474K Buy
+4,304
New +$430K 0.22% 160

Other funds holding ABT

Everpar Advisors's ABT Position: Q2 2026 in Review

Everpar Advisors increased its Abbott (ABT) stake by 24% in Q2 2026, buying an estimated $108K and bringing the position to 6,199 shares worth $562K. The position accounts for 0.16% of the portfolio, ranked #133.

Everpar Advisors first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $602K in Q2 2025. 530 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Everpar Advisors held 6,199 shares of Abbott worth $562K as of Q2 2026.
  • Everpar Advisors bought 1,182 Abbott shares in Q2 2026, an estimated $108K.
  • Abbott made up 0.16% of Everpar Advisors's portfolio in Q2 2026, its #133 holding.
  • Everpar Advisors first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Everpar Advisors's Abbott position peaked at $602K in Q2 2025.
  • 530 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.